Op-ed: DEA and FDA rules exacerbate Adderall shortage
30mg tablets of Shire Plc's Adderall XR.JB Reed | Bloomberg | Getty ImagesJosh Disbrow is chairman and chief executive officer of Aytu BioPharma, which makes a competing drug to treat ADHD …